Small Cap Segment Shows Mixed Trend, Upgraded Stocks Offer Potential Growth Opportunities
The small cap segment has been the best performer, with Schneider Elect. showing a return of 14.97%, while Astrazeneca Phar has been the worst performer with a return of -13.25%. The advance decline ratio for stocks in this segment is currently at 1.23x, indicating a mixed trend. Upcoming results of key stocks and upgrades in stock scores and technical calls could have a significant impact on the market and present potential opportunities for investors.
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
